News & events
Press Releases
On the 28th March 2022, OncoArendi changed its name to Molecure
OncoArendi Therapeutics to Begin the Phase 1 Clinical Evaluation of its Novel Class of Medicines
9 October 2017
OncoArendi Therapeutics announced today that it has filed a Clinical Trial Application (CTA)
7 July 2017
OncoArendi Therapeutics Announces Selection of Its Second Clinical Development Candidate: OATD-02 For the Treatment of Multiple Cancers
21 June 2017
OncoArendi raises 4.5 mln USD (18 million PLN) in an extension of Series A financing round
8 March 2017
OncoArendi receives the President’s Economic Award as the best Polish R&D Company in 2016
17 November 2016
Events & Presentations
EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018
17 September 2018
54th International Conference on Medicinal Chemistry, Strasbourg, France – July 4-6, 2018.
17 July 2018
AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, October 26 – 30, 2017
1 October 2017